To report the results of implantation of an angle-supported phakic anterior chamber IOL (pIOL) for myopia

Session Details

Session Title: Interactive Free Paper Session: Anterior chamber phakic IOLS

Session Date/Time: Tuesday 16/09/2014 | 16:30-18:00

Paper Time: 17:36

Venue: Auditorium

First Author: : R.Lapid-Gortzak THE NETHERLANDS

Co Author(s): :    J. van der Linden   V. Vrijman   I. van der Meulen        

Abstract Details

Purpose:

Prospectively gathered data on 59 eyes (31 patients) implanted with a pIOL (Acrysof Cachet, Alcon, USA) for a mean myopia of -9.48 + 2.83 was analyzed. Outcome measures were visual and refractive parameters, endothelial cell count, as well as incidence of complications.

Setting:

Private Refractive Surgery Clinic.

Methods:

Prospectively gathered data on 59 eyes (31 patients) implanted with a pIOL (Acrysof Cachet, Alcon, USA) for a mean myopia of -9.48 + 2.83 was analyzed. Outcome measures were visual and refractive parameters, endothelial cell count, as well as incidence of complications.

Results:

Postoperatively at 6 months 77% were within 0.5 D of emmetropia, and 89% were within 1 D of emmetropia. Mean postoperative uncorrected distance visual acuity (UDVA) was logMAR -0.01 + -0.15, and the mean spherical equivalent (SE) was -0.17 D + 0.40. Complications were: early pressure rise (8 eyes), mild postoperative uveitis (3 eyes), synechiae at haptics (3 eyes), localized synechiae formation at haptics (3), and localized asymptomatic retinal detachments (2 eyes). One pIOL was exchanged in tra-operatively because of sizing problems. ECC was stable throughout the first 24 months, with a decrease from 36 months in a few patients.

Conclusions:

The pIOL gives excellent results in terms of UVDA and refraction, with a good safety profile within the first few years after implantation. The longterm safety still remains to be proven.

Financial Interest:

NONE